Recent advances in small molecules for amyloid fibril inhibition: chemical strategies and molecular mechanistic insights from lysozyme and insulin models

Key Points

• Inhibition of amyloid fibrils was demonstrated using newly developed small molecules, enhancing therapeutic strategies.
• Significant reduction of amyloid fibrils was observed in both lysozyme and insulin models, indicating potential effectiveness.
• Analysis focused on chemical strategies and molecular mechanisms underlying the inhibition of fibril formation.
• Supports the need for further exploration into small molecule therapies targeting amyloid-related conditions.